In leukemia, reduced phosphorylation at these sites strengthens the interaction between HSP90 and APAF1, inhibiting cytochrome c-induced apoptosome assembly and contributing to chemoresistance (Ho et al., 2012). Here, HSP90AB1 is linked to leukemia.